Cassian Yee

17.9k total citations · 5 hit papers
156 papers, 11.6k citations indexed

About

Cassian Yee is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Cassian Yee has authored 156 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 101 papers in Immunology and 38 papers in Molecular Biology. Recurrent topics in Cassian Yee's work include CAR-T cell therapy research (72 papers), Immunotherapy and Immune Responses (62 papers) and Immune Cell Function and Interaction (43 papers). Cassian Yee is often cited by papers focused on CAR-T cell therapy research (72 papers), Immunotherapy and Immune Responses (62 papers) and Immune Cell Function and Interaction (43 papers). Cassian Yee collaborates with scholars based in United States, Australia and South Korea. Cassian Yee's co-authors include Philip D. Greenberg, Thomas A. Spies, Veronika Groh, Jennifer D. Wu, Stanley R. Riddell, John A. Thompson, Mark M. Davis, Peter P. Lee, Patrick C. Roche and John A. Thompson and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Cassian Yee

151 papers receiving 11.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

2002 1.3k citations Veronika Groh, Cassian Yee et al. profile →
Adoptive T cell therapy using antigen-specific CD8⁺T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells

2002 941 citations Cassian Yee, Stanley R. Riddell et al. Proceedings of the National Academy of Sciences profile →
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1999 919 citations Cassian Yee, Philip D. Greenberg et al. profile →
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

2008 704 citations Naomi Hunder, Cassian Yee et al. profile →
Generation and testing of clinical-grade exosomes for pancreatic cancer

2018 633 citations Cassian Yee et al. JCI Insight profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cassian Yee United States	51	7.6k	6.4k	2.9k	1.1k	744	156	11.6k
Andréas Mackensen Germany	52	6.5k 0.9×	5.0k 0.8×	3.4k 1.2×	773 0.7×	1.6k 2.2×	253	11.0k
Christopher A. Klebanoff United States	41	7.9k 1.0×	7.9k 1.2×	3.0k 1.0×	1.7k 1.5×	685 0.9×	77	11.7k
Chrystal M. Paulos United States	39	5.5k 0.7×	5.4k 0.8×	2.3k 0.8×	1.1k 0.9×	436 0.6×	132	9.2k
Dallas B. Flies United States	38	10.6k 1.4×	9.4k 1.5×	2.3k 0.8×	579 0.5×	755 1.0×	65	14.9k
Ana C. Anderson United States	50	12.2k 1.6×	7.8k 1.2×	3.3k 1.2×	543 0.5×	530 0.7×	96	15.6k
Koji Tamada Japan	54	11.8k 1.6×	10.6k 1.7×	2.8k 1.0×	922 0.8×	863 1.2×	147	17.4k
Beatriz M. Carreno United States	40	8.4k 1.1×	5.6k 0.9×	2.1k 0.7×	576 0.5×	488 0.7×	75	11.3k
Zhiya Yu United States	54	8.6k 1.1×	8.8k 1.4×	3.9k 1.4×	2.4k 2.1×	751 1.0×	95	14.2k
Michael H. Kershaw Australia	50	6.4k 0.8×	7.6k 1.2×	2.8k 1.0×	2.0k 1.7×	452 0.6×	132	11.0k
Gefeng Zhu United States	34	9.1k 1.2×	8.5k 1.3×	2.0k 0.7×	466 0.4×	633 0.9×	44	13.3k

Countries citing papers authored by Cassian Yee

Since Specialization

Citations

This map shows the geographic impact of Cassian Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassian Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassian Yee more than expected).

Fields of papers citing papers by Cassian Yee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cassian Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassian Yee. The network helps show where Cassian Yee may publish in the future.

Co-authorship network of co-authors of Cassian Yee

This figure shows the co-authorship network connecting the top 25 collaborators of Cassian Yee. A scholar is included among the top collaborators of Cassian Yee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cassian Yee. Cassian Yee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saberian, Chantal, Denái R. Milton, Julie M. Simon, et al.. (2024). Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neuro-Oncology Practice. 11(4). 452–463. 1 indexed citations

Cho, Min Soon, et al.. (2023). The impact of the complement receptors C3aR1 and C5aR1 on the progression of melanoma. The Journal of Immunology. 210(Supplement_1). 89.09–89.09. 1 indexed citations

Lee, Hyo-Jung, Kwon‐Ho Song, Se Jin Oh, et al.. (2022). Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes. Nature Communications. 13(1). 2127–2127. 12 indexed citations

Zamler, Daniel, Takashi Shingu, Laura M. Kahn, et al.. (2022). Immune landscape of a genetically engineered murine model of glioma compared with human glioma. JCI Insight. 7(12). 16 indexed citations

Huuhtanen, Jani, Liang Chen, Emmi Jokinen, et al.. (2022). Evolution and modulation of antigen-specific T cell responses in melanoma patients. Nature Communications. 13(1). 5988–5988. 22 indexed citations

Puebla‐Osorio, Nahum, Robin Michelet, Michael R. Green, et al.. (2021). Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model. Cancers. 13(11). 2782–2782. 30 indexed citations

Wang, Junmei, Haiyan S. Li, Jungsun Park, et al.. (2020). Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells. Cancer Immunology Research. 8(6). 794–805. 17 indexed citations

Kim, Suyeon, Hanbyoul Cho, Se Jin Oh, et al.. (2020). LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells. Autophagy. 17(8). 1978–1997. 41 indexed citations

Park, Gayoung, Jeongmin Kim, Seon Ah Lim, et al.. (2019). CD160 serves as a negative regulator of NKT cells in acute hepatic injury. Nature Communications. 10(1). 25 indexed citations

10.

Kohli, Karan, Yao Lu, Qianchuan He, et al.. (2019). Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer Immunology Research. 7(8). 1237–1243. 101 indexed citations

11.

Lim, Seon Ah, Seunghyun Jeon, Min Hwa Shin, et al.. (2019). Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Frontiers in Immunology. 10. 496–496. 79 indexed citations

12.

Oh, Se Jin, Hanbyoul Cho, Suhyun Kim, et al.. (2018). Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3–NANOG Axis. Cancer Research. 78(10). 2638–2653. 29 indexed citations

13.

Park, Jungsun, Amjad H. Talukder, Seon Ah Lim, et al.. (2017). SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. Cancer Immunology Research. 5(8). 618–629. 24 indexed citations

14.

Song, Kwon‐Ho, Chel Hun Choi, Hyo‐Jung Lee, et al.. (2017). HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. Cancer Research. 77(18). 5039–5053. 72 indexed citations

15.

Noh, Kyung Hee, Jin Hee Kim, Kwon‐Ho Song, et al.. (2014). API5 Confers Tumoral Immune Escape through FGF2-Dependent Cell Survival Pathway. Cancer Research. 74(13). 3556–3566. 45 indexed citations

16.

Chapuis, Aude G., Gunnar B. Ragnarsson, Hieu Nguyen, et al.. (2013). Transferred WT1-Reactive CD8 ⁺ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients. Science Translational Medicine. 5(174). 174ra27–174ra27. 242 indexed citations

17.

Lim, Seon Ah, Tae-Jin Kim, Jung Eun Lee, et al.. (2013). Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy. Cancer Research. 73(8). 2598–2607. 52 indexed citations

18.

Iyer, Jayasri G., Olga K. Afanasiev, Christopher L. McClurkan, et al.. (2011). Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood. Clinical Cancer Research. 17(21). 6671–6680. 115 indexed citations

19.

Euw, Erika M. von, María Marcela Barrio, David Furman, et al.. (2008). A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression. Journal of Translational Medicine. 6(1). 6–6. 58 indexed citations

20.

Groh, Veronika, Daniel Cioca, Naomi Hunder, et al.. (2005). Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. Proceedings of the National Academy of Sciences. 102(18). 6461–6466. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact